Spurs injury updates ahead of West Ham clash: Son, Richarlison and Odobert

Spurs injury updates ahead of West Ham clash: Son, Richarlison and Odobert
Spurs injury updates ahead of West Ham clash: Son, Richarlison and Odobert

As Tottenham Hotspur prepare for their upcoming clash against West Ham United this Saturday, questions remain regarding the availability of key players. With Heung-Min Son, Richarlison de Andrade and Wilson Odobert nursing injuries, fans are eagerly awaiting news on their fitness ahead of this crucial encounter.

To start with Son, the South Korean star opted out of international duty during this break, battling a thigh injury that sidelined him for three consecutive matches. However, a glimmer of hope emerged when he took to Instagram, posting a message that read “Being back soon.” This optimistic rating suggests he could return to training this week, which would bolster Spurs’ attacking options.

On the other hand, Richarlison’s situation remains a bit enigmatic. Coach Ange Postecoglou has been particularly testy with the press regarding updates on the Brazilian’s calf injury. Previously, he urged journalists to refrain from seeking information until he felt ready to release it. Despite this shroud of secrecy, Richarlison was recently seen taking part in on-field training exercises, fueling speculation about his imminent return. While this weekend’s game may not be ideal for him, it looks like he won’t be out much longer.

Meanwhile, Wilson Odobert is also in the race, dealing with a hamstring injury. There is a possibility he could make the squad for the game against West Ham or even be considered for the subsequent Europa League game. His return to training could also happen as early as this week, adding another layer of depth to Postecoglou’s options.

These developments will undoubtedly be crucial as Spurs look to secure vital points against their London rivals. Stay tuned for team updates as the game approaches!

Senegal

-

-

PREV Lucie Calba set off to discover the women’s D1 with Stade de Reims
NEXT Doliprane sold to an American group: a headache for French health sovereignty?